The twice-yearly shot lenacapavir, sold under the name Yeztugo, reportedly nearly eliminated new HIV infections in studies of ...

The Bohol Provincial Health Office (PHO) has confirmed that all local governments in Bohol — including the capital city of ...

The Trump administration’s budget proposal sends a dangerous message: that the lives and health of people living with HIV are ...

This article explores the complex interplay between drug addiction and HIV, highlighting how integrated harm reduction ...

Antiretroviral therapy (ART) initiated in the acute phase of HIV infection (AHI) results in a smaller viral reservoir. However, the impact of early HIV-specific T-cell responses on long-term reservoir ...

While a Coastal Bend organization's free HIV testing will likely end July 1 due to a grant pause, the health district promises to continue services.

Over 1,200 individuals gathered at Kapiʻolani Park on June 21 to participate in the 34th annual Walk for Life, Honolulu’s ...

The White House budget proposal would roll back next year's federal HIV prevention funding to levels not seen since around ...

The National Institutes of Health office responsible for issuing federal guidelines related to treatment of HIV and AIDS ...

The National Institutes of Health will phase out its support of the clinical practice guidelines that advise doctors how to diagnose and treat HIV.

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be HIV-negative to get it.

The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts ...